QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Raymond James analyst Michael Rose initiates coverage on Firstsun Capital (NASDAQ:FSUN) with a Market Perform rating.

Core News & Articles

No Action Required From Shareholders

Core News & Articles

an increase in FirstSun's total equity capital raised in connection with the merger of an additional $45 million to $60 mil...

Core News & Articles

Combined assets of approximately $17 billion Dallas, Texas headquartered bank with an extensive footprint in 6 of the top 10...

 the-daily-biotech-pulse-illumina-announces-multiple-partnerships-immunome-slides-on-regulatory-setback-for-covid-antibody-drug-preannouncements-pour-in

Here's a roundup of top developments in the biotech space over the last 24 hours:

 the-daily-biotech-pulse-modernas-vaccine-produces-durable-response-against-variants-fda-approves-jazzs-sleep-disorder-drug-dermata-ipo

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 the-daily-biotech-pulse-astrazeneca-biogen-face-clinical-trial-disappointments-novavax-studies-coronavirus-flu-combo-vaccine-decision-day-for-takeda

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION